Switching to Duloxetine From Selective Serotonin Reuptake Inhibitor Antidepressants
David Pérahia(École Normale Supérieure Paris-Saclay), Maurizio Fava(Unknown), D. Desaiah(Eli Lilly (United States)), Deborah Quail(Eli Lilly (United Kingdom)), Emmanuelle Corruble(Inserm)
Cited by 46
Related Papers
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)
|Biological Psychiatry|2003|541
Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents
|Biological Psychiatry|2007|302